Top

Emerald Health Therapeutics Inc.

TSXV Exchange | Feb 20, 2020, 1:00 AM EST | Real-time price

EMH $ 0.22 RT
CHANGE
-0.005 (-2.2222%)
VOLUME
471,578
Day Low: 0.21
Day High: 0.225
Detailed Quote
Open: 0.22
High: 0.225
Beta: 1.7153
Shares Out.: 183,582,448
Total Shares (All Classes)2: 182,367,493
Prev. Close: 0.225
Low: 0.21
VWAP: 0.2166
Escrow Shares: 4,955,947
Market Cap (All Classes)2*: 40,120,848
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 188,538,395
EPS: -0.24
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 0.212
Market Cap1: 41,478,447
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.

Description

Emerald Health Therapeutics Inc is a vertically integrated Canadian licensed producer of cannabis, focused on developing proprietary, cannabis products for medical and adult-use customers. The company's Pure Sunfarms joint venture has two 1.1 M sf greenhouses. The Verdelite operation in Quebec is an approx. 88,000 sf indoor facility licensed for cultivation and production. It has contracted around 1000 acres of hemp in 2019 to 2022. Through strategic partnerships, the company has secured industr... More

News Headlines for Emerald Health Therapeutics Inc.
Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

GlobeNewswire , 10:11 PM EST February 14, 2020

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

GlobeNewswire , 10:45 PM EST February 06, 2020

Emerald Health Therapeutics Closes Shares for Debt Financing

GlobeNewswire , 1:52 PM EST January 31, 2020

Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links
News Headlines for Emerald Health Therapeutics Inc.
Emerald Health Therapeutics Closes Final Tranche Prospectus Sale

GlobeNewswire , 10:11 PM EST February 14, 2020

Emerald Health Therapeutics Closes $2.2 Million Prospectus Sale

GlobeNewswire , 10:45 PM EST February 06, 2020

Emerald Health Therapeutics Closes Shares for Debt Financing

GlobeNewswire , 1:52 PM EST January 31, 2020

Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.